Evidence map›Paper›PMID 24478366›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration.

Edith Arnold, Stéphanie Thebault, German Baeza-Cruz, David Arredondo Zamarripa, Norma Adán, Andrés Quintanar-Stéphano, Miguel Condés-Lara, Gerardo Rojas-Piloni, Nadine Binart, Gonzalo Martínez de la Escalera and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03161652 (Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03161652 phase2recruitingnot on this mapstarted 2017, after this paper: background citation

Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.

TypeinterventionalSponsorCarmen ClappRan2017 to 2027Enrolled120ConditionsDiabetic Macular Edema, Diabetic RetinopathyArmsDME lactose pill, DME levosulpiride, DR lactose pill, DR levosulpiride, DR vitrectomy lactose pill
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neuroprotective Peptides in Retinal Disease.Journal of clinical medicine · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?International journal of molecular sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Edith ArnoldInstituto de Neurobiología, Universidad Nacional Autónoma de México, Campus UNAM-Juriquilla, 76230 Querétaro, México, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, 20100 Aguascalientes, México, and Institut National de la Santé et de la Recherche Médicale, U693, Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre 94270, France.
Stéphanie Thebault
German Baeza-Cruz
David Arredondo Zamarripa
Norma Adán
Andrés Quintanar-Stéphano
Miguel Condés-Lara
Gerardo Rojas-Piloni
Nadine Binart
Gonzalo Martínez de la Escalera
Carmen Clapp
Universidad Nacional Autónoma de México · MXAutonomous University of Aguascalientes · MXUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal degeneration is characterized by the progressive destruction of retinal cells, causing the deterioration and eventual loss of vision. We explored whether the hormone prolactin provides trophic support to retinal cells, thus protecting the retina from degenerative pressure. Inducing hyperprolactinemia limited photoreceptor apoptosis, gliosis, and changes in neurotrophin expression, and it preserved the photoresponse in the phototoxicity model of retinal degeneration, in which continuous exposure of rats to bright light leads to retinal cell death and retinal dysfunction. In this model, the expression levels of prolactin receptors in the retina were upregulated. Moreover, retinas from prolactin receptor-deficient mice exhibited photoresponsive dysfunction and gliosis that correlated with decreased levels of retinal bFGF, GDNF, and BDNF. Collectively, these data unveiled prolactin as a retinal trophic factor that may regulate glial-neuronal cell interactions and is a potential therapeutic molecule against retinal degeneration.

Indexed as

Analysis of VarianceAnimalsApoptosisDisease Models, AnimalElectroretinographyFemaleGene Expression RegulationGlial Fibrillary Acidic ProteinGliosisHyperprolactinemiaIntercellular Signaling Peptides and ProteinsLightMaleMiceMice, TransgenicNeurogliaGlial Fibrillary Acidic ProteinIntercellular Signaling Peptides and ProteinsProlactinReceptors, ProlactinRNA, Messengergliosisprolactinretinal degenerationtrophic factor

Identifiers

PMID24478366
PMCPMC6827588
OpenAlexW2152762327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.